© 1997 American Heart Association, Inc.
Articles |
Rapamycin Inhibits 
1-Adrenergic Receptor–Stimulated Cardiac Myocyte Hypertrophy but Not Activation of Hypertrophy-Associated Genes
Evidence for Involvement of p70 S6 Kinase
From the Laboratory of Cardiovascular Science (M.O.B., J-S.Z., X.L., L.O., E.G.L., M.T.C.), Gerontology Research Center, National Institute on Aging, National Institutes of Health, Baltimore, Md; Département de Biologie Appliquée (A.Y.), Institut Universitaire de Technologie de Clermont-Ferrand, Aubière, France; and the Division of Cardiology (H.S.), Johns Hopkins Hospital, Baltimore, Md.
Correspondence to Marvin O. Boluyt, PhD, Laboratory of Cardiovascular Science, National Institute on Aging, Gerontology Research Center, 4940 Eastern Ave, Baltimore, MD 21224. E-mail marvinb{at}vax.grc.nia.nih.gov
Abstract The 70-kD S6 kinase (p70S6K) has been
implicated in the regulation of protein synthesis in many cell types
and in the angiotensin II–stimulated
hypertrophy of cardiac myocytes. Our purpose was to
determine whether p70S6K plays a role in
cardiomyocyte hypertrophy induced by the
1-adrenergic receptor (1-AR) agonist
phenylephrine (PE). PE stimulated the activity of
p70S6K >3-fold, and this increase was blocked by
rapamycin, an immunosuppressant macrolide that selectively inhibits
p70S6K. When administered for 3 days, PE stimulated a 30%
increase in total protein content, a 2-fold increase in the
incorporation of [14C]phenylalanine (14C-Phe)
into protein, and a 50% increase in two-dimensional myocyte area.
Rapamycin pretreatment (
500 pg/mL) significantly inhibited each of
these PE-stimulated changes. Two days of PE treatment resulted in a
1.6-fold increase in total RNA yield per dish, a 2-fold increase in
incorporation of [14C]uridine into myocyte RNA, and
increases in relative mRNA levels of the
hypertrophy-associated atrial natriuretic
factor (ANF, 2.1-fold) and skeletal -actin (SK, 2.2-fold) genes.
Although rapamycin abolished the PE-stimulated increases in total RNA
and incorporation of [14C]uridine, it had no effect on
the induction of the ANF and SK genes. LY294002, a specific
inhibitor of phosphatidylinositol 3-kinase (PI3-K)
activity, inhibited PE-stimulated increases in p70S6K
activity and the incorporation of labeled precursors into myocyte
protein and RNA. These results demonstrate that p70S6K is
activated by the hypertrophic agent PE and that a PI3-K or
PI3-K–like activity is required for p70S6K activation and
myocyte hypertrophy. The data suggest that
p70S6K activation may be required for PE-stimulated
hypertrophy of cardiac myocytes. Our results demonstrate
that intracellular signaling pathways responsible for transcriptional
and translational responses diverge early after 1-AR
stimulation in cardiac myocytes.
Key Words: ribosomal S6-kinase • 1-adrenergic receptor • immunosuppressant drug • rapamycin • phosphatidylinositol-3 kinase
This article has been cited by other articles:
 |
|
 |
|
  B. P. H. Huang, Y. Wang, X. Wang, Z. Wang, and C. G. Proud Blocking eukaryotic initiation factor 4F complex formation does not inhibit the mTORC1-dependent activation of protein synthesis in cardiomyocytes Am J Physiol Heart Circ Physiol, February 1, 2009; 296(2): H505 - H514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Y. M. Chan, V. W. Dolinsky, C.-L. M. Soltys, B. Viollet, S. Baksh, P. E. Light, and J. R. B. Dyck Resveratrol Inhibits Cardiac Hypertrophy via AMP-activated Protein Kinase and Akt J. Biol. Chem., August 29, 2008; 283(35): 24194 - 24201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-H. Shen, Z. Chen, S. Shi, H. Chen, W. Zhu, A. Penner, G. Bu, W. Li, D. W. Boyle, M. Rubart, et al. Cardiac Restricted Overexpression of Kinase-dead Mammalian Target of Rapamycin (mTOR) Mutant Impairs the mTOR-mediated Signaling and Cardiac Function J. Biol. Chem., May 16, 2008; 283(20): 13842 - 13849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Guan, K. Song, M. A. Pysz, K. J. Curry, A. A. Hizli, D. Danielpour, A. R. Black, and J. D. Black Protein Kinase C-mediated Down-regulation of Cyclin D1 Involves Activation of the Translational Repressor 4E-BP1 via a Phosphoinositide 3-Kinase/Akt-independent, Protein Phosphatase 2A-dependent Mechanism in Intestinal Epithelial Cells J. Biol. Chem., May 11, 2007; 282(19): 14213 - 14225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Nader, T. J. McLoughlin, and K. A. Esser mTOR function in skeletal muscle hypertrophy: increased ribosomal RNA via cell cycle regulators Am J Physiol Cell Physiol, December 1, 2005; 289(6): C1457 - C1465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Baar New dimensions in tissue engineering: possible models for human physiology Exp Physiol, November 1, 2005; 90(6): 799 - 806. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Schoffstall, A. Kataoka, A. Clark, and P. B. Chase Effects of Rapamycin on Cardiac and Skeletal Muscle Contraction and Crossbridge Cycling J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 12 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Kim and J. Chen Regulation of Peroxisome Proliferator-Activated Receptor-{gamma} Activity by Mammalian Target of Rapamycin and Amino Acids in Adipogenesis Diabetes, November 1, 2004; 53(11): 2748 - 2756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Chandrasekher and D. Sailaja Phosphatidylinositol 3-Kinase (PI-3K)/Akt but Not PI-3K/p70 S6 Kinase Signaling Mediates IGF-1-Promoted Lens Epithelial Cell Survival Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3577 - 3588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. McMullen, T. Shioi, L. Zhang, O. Tarnavski, M. C. Sherwood, A. L. Dorfman, S. Longnus, M. Pende, K. A. Martin, J. Blenis, et al. Deletion of Ribosomal S6 Kinases Does Not Attenuate Pathological, Physiological, or Insulin-Like Growth Factor 1 Receptor-Phosphoinositide 3-Kinase-Induced Cardiac Hypertrophy Mol. Cell. Biol., July 15, 2004; 24(14): 6231 - 6240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. McMullen, M. C. Sherwood, O. Tarnavski, L. Zhang, A. L. Dorfman, T. Shioi, and S. Izumo Inhibition of mTOR Signaling With Rapamycin Regresses Established Cardiac Hypertrophy Induced by Pressure Overload Circulation, June 22, 2004; 109(24): 3050 - 3055. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Frey, H. A. Katus, E. N. Olson, and J. A. Hill Hypertrophy of the Heart: A New Therapeutic Target? Circulation, April 6, 2004; 109(13): 1580 - 1589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Morris, T. M. Pham, B. Kenney, K. E. Sheppard, and E. A. Woodcock UTP Transactivates Epidermal Growth Factor Receptors and Promotes Cardiomyocyte Hypertrophy Despite Inhibiting Transcription of the Hypertrophic Marker Gene, Atrial Natriuretic Peptide J. Biol. Chem., March 5, 2004; 279(10): 8740 - 8746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. O. Boluyt, A. M. Loyd, M. H. Roth, M. J. Randall, and E. Y. M. Song Activation of JNK in rat heart by exercise: effect of training Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2639 - H2647. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. N. Olson and M. D. Schneider Sizing up the heart: development redux in disease Genes & Dev., August 15, 2003; 17(16): 1937 - 1956. [Full Text] [PDF]
|
|
|
|
|
|
T. Shioi, J. R. McMullen, O. Tarnavski, K. Converso, M. C. Sherwood, W. J. Manning, and S. Izumo Rapamycin Attenuates Load-Induced Cardiac Hypertrophy in Mice Circulation, April 1, 2003; 107(12): 1664 - 1670. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Depre, M. Hase, V. Gaussin, A. Zajac, L. Wang, L. Hittinger, B. Ghaleh, X. Yu, R. K. Kudej, T. Wagner, et al. H11 Kinase Is a Novel Mediator of Myocardial Hypertrophy In Vivo Circ. Res., November 29, 2002; 91(11): 1007 - 1014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shioi, J. R. McMullen, P. M. Kang, P. S. Douglas, T. Obata, T. F. Franke, L. C. Cantley, and S. Izumo Akt/Protein Kinase B Promotes Organ Growth in Transgenic Mice Mol. Cell. Biol., April 15, 2002; 22(8): 2799 - 2809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. C. Tu, J. J. Bahl, and Q. M. Chen Signals of Oxidant-Induced Cardiomyocyte Hypertrophy: Key Activation of p70 S6 Kinase-1 and Phosphoinositide 3-Kinase J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 1101 - 1110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. F Bueno, E. van Rooij, J. D Molkentin, P. A Doevendans, and L. J De Windt Calcineurin and hypertrophic heart disease: novel insights and remaining questions Cardiovasc Res, March 1, 2002; 53(4): 806 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zhang Old and new tools to dissect calcineurin's role in pressure-overload cardiac hypertrophy Cardiovasc Res, February 1, 2002; 53(2): 294 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sanada, M. Kitakaze, K. Node, S. Takashima, A. Ogai, H. Asanuma, Y. Sakata, M. Asakura, H. Ogita, Y. Liao, et al. Differential Subcellular Actions of ACE Inhibitors and AT1 Receptor Antagonists on Cardiac Remodeling Induced by Chronic Inhibition of NO Synthesis in Rats Hypertension, September 1, 2001; 38(3): 404 - 411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Korzick, D. A. Holiman, M. O. Boluyt, M. H. Laughlin, and E. G. Lakatta Diminished {alpha}1-adrenergic-mediated contraction and translocation of PKC in senescent rat heart Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H581 - H589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Everett, T. D. Stoops, A. C. Nairn, and D. Brautigan Angiotensin II regulates phosphorylation of translation elongation factor-2 in cardiac myocytes Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H161 - H167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Nader and K. A. Esser Intracellular signaling specificity in skeletal muscle in response to different modes of exercise J Appl Physiol, May 1, 2001; 90(5): 1936 - 1942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. PODDER, S. M. STEPKOWSKI, K. L. NAPOLI, J. CLARK, R. R. VERANI, T.-C. CHOU, and B. D. KAHAN Pharmacokinetic Interactions Augment Toxicities of Sirolimus/Cyclosporine Combinations J. Am. Soc. Nephrol., May 1, 2001; 12(5): 1059 - 1071. [Abstract] [Full Text]
|
|
|
|
|
|
H. Kodama, K. Fukuda, J. Pan, M. Sano, T. Takahashi, T. Kato, S. Makino, T. Manabe, M. Murata, and S. Ogawa Significance of ERK cascade compared with JAK/STAT and PI3-K pathway in gp130-mediated cardiac hypertrophy Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1635 - H1644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. H. Pham, P. H. Sugden, and A. Clerk Regulation of Protein Kinase B and 4E-BP1 by Oxidative Stress in Cardiac Myocytes Circ. Res., June 23, 2000; 86(12): 1252 - 1258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sabri, G. Muske, H. Zhang, E. Pak, A. Darrow, P. Andrade-Gordon, and S. F. Steinberg Signaling Properties and Functions of Two Distinct Cardiomyocyte Protease-Activated Receptors Circ. Res., May 26, 2000; 86(10): 1054 - 1061. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. O. Boluyt and O. H.L. Bing Matrix gene expression and decompensated heart failure: The aged SHR model Cardiovasc Res, May 1, 2000; 46(2): 239 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Liu, X. Shen, V.-A. Nguyen, G. Kunos, and B. Gao alpha 1 Adrenergic Agonist Induction of p21waf1/cip1 mRNA Stability in Transfected HepG2 Cells Correlates with the Increased Binding of an AU-rich Element Binding Factor J. Biol. Chem., April 14, 2000; 275(16): 11846 - 11851. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. I. Rybkin, M. E. Cross, E. M. McReynolds, R. Z. Lin, and L. M. Ballou alpha 1A Adrenergic Receptor Induces Eukaryotic Initiation Factor 4E-binding Protein 1 Phosphorylation via a Ca2+-dependent Pathway Independent of Phosphatidylinositol 3-kinase/Akt J. Biol. Chem., February 25, 2000; 275(8): 5460 - 5465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Ballou, M. E. Cross, S. Huang, E. M. McReynolds, B.-X. Zhang, and R. Z. Lin Differential Regulation of the Phosphatidylinositol 3-Kinase/Akt and p70 S6 Kinase Pathways by the alpha 1A-Adrenergic Receptor in Rat-1 Fibroblasts J. Biol. Chem., February 18, 2000; 275(7): 4803 - 4809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V.-A. T. Nguyen and B. Gao Cross-talk between alpha 1B-Adrenergic Receptor (alpha 1BAR) and Interleukin-6 (IL-6) Signaling Pathways. ACTIVATION OF alpha 1BAR INHIBITS IL-6-ACTIVATED STAT3 IN HEPATIC CELLS BY A p42/44 MITOGEN-ACTIVATED PROTEIN KINASE-DEPENDENT MECHANISM J. Biol. Chem., December 10, 1999; 274(50): 35492 - 35498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Baliga, D. R. Pimental, Y.-Y. Zhao, W. W. Simmons, M. A. Marchionni, D. B. Sawyer, and R. A. Kelly NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70S6K, and MEK-MAPK-RSK Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H2026 - H2037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Masugata, S. Senda, A. Kinoshita, Xin Lu, H. Sakamoto, S. Sakamoto, H. Matsuo, and K. Mizushige Tissue Characterization of Myocardial Cells by Use of High-Frequency Acoustic Microscopy: Differential Myocyte Sound Speed and Its Transmural Variation in Normal, Pressure-Overload Hypertrophic, and Amyloid Myocardium Angiology, October 1, 1999; 50(10): 837 - 845. [Abstract] [PDF]
|
|
|
|
|
|
G. Nikcevic, M. C. Heidkamp, M. Perhonen, and B. Russell Mechanical activity in heart regulates translation of alpha -myosin heavy chain mRNA but not its localization Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H2013 - H2019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. N. Olson and J. D. Molkentin Prevention of Cardiac Hypertrophy by Calcineurin Inhibition : Hope or Hype? Circ. Res., April 2, 1999; 84(6): 623 - 632. [Full Text] [PDF]
|
|
|
|
|
|
P. H. Sugden Signaling in Myocardial Hypertrophy : Life After Calcineurin? Circ. Res., April 2, 1999; 84(6): 633 - 646. [Full Text] [PDF]
|
|
|
|
|
|
K. Baar and K. Esser Phosphorylation of p70S6k correlates with increased skeletal muscle mass following resistance exercise Am J Physiol Cell Physiol, January 1, 1999; 276(1): C120 - C127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Laser, V. S. Kasi, M. Hamawaki, G. Cooper IV, C. M. Kerr, and D. Kuppuswamy Differential Activation of p70 and p85 S6 Kinase Isoforms during Cardiac Hypertrophy in the Adult Mammal J. Biol. Chem., September 18, 1998; 273(38): 24610 - 24619. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Kunapuli, J. A. Lawson, J. A. Rokach, J. L. Meinkoth, and G. A. FitzGerald Prostaglandin F2alpha (PGF2alpha ) and the Isoprostane, 8,12-iso-Isoprostane F2alpha -III, Induce Cardiomyocyte Hypertrophy. DIFFERENTIAL ACTIVATION OF DOWNSTREAM SIGNALING PATHWAYS J. Biol. Chem., August 28, 1998; 273(35): 22442 - 22452. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Kometiani, J. Li, L. Gnudi, B. B. Kahn, A. Askari, and Z. Xie Multiple Signal Transduction Pathways Link Na+/K+-ATPase to Growth-related Genes in Cardiac Myocytes. THE ROLES OF Ras AND MITOGEN-ACTIVATED PROTEIN KINASES J. Biol. Chem., June 12, 1998; 273(24): 15249 - 15256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Homcy Signaling Hypertrophy : How Many Switches, How Many Wires Circulation, May 19, 1998; 97(19): 1890 - 1892. [Full Text] [PDF]
|
|
|
|
|
|
H. Oh, Y. Fujio, K. Kunisada, H. Hirota, H. Matsui, T. Kishimoto, and K. Yamauchi-Takihara Activation of Phosphatidylinositol 3-Kinase through Glycoprotein 130 Induces Protein Kinase B and p70 S6 Kinase Phosphorylation in Cardiac Myocytes J. Biol. Chem., April 17, 1998; 273(16): 9703 - 9710. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Koyama, N. E. Olson, F. F. Dastvan, and M. A. Reidy Cell Replication in the Arterial Wall : Activation of Signaling Pathway Following In Vivo Injury Circ. Res., April 6, 1998; 82(6): 713 - 721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-S. Zheng, L. O'Neill, X. Long, T. E Webb, E. A Barnard, E. G Lakatta, and M. O Boluyt Stimulation of P2Y receptors activates c-fos gene expression and inhibits DNA synthesis in cultured cardiac fibroblasts Cardiovasc Res, March 1, 1998; 37(3): 718 - 728. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wang, I. Gout, and C. G. Proud Cross-talk between the ERK and p70 S6 Kinase (S6K) Signaling Pathways. MEK-DEPENDENT ACTIVATION OF S6K2 IN CARDIOMYOCYTES J. Biol. Chem., August 24, 2001; 276(35): 32670 - 32677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Lin, W. A. Owens, S. Chen, M. E. Stevens, S. Kesteven, J. F. Arthur, E. A. Woodcock, M. P. Feneley, and R. M. Graham Targeted {alpha}1A-Adrenergic Receptor Overexpression Induces Enhanced Cardiac Contractility but not Hypertrophy Circ. Res., August 17, 2001; 89(4): 343 - 350. [Abstract] [Full Text] [PDF]
|
|